CRT 2023

Is Targeting Platelets and Coagulation Sufficient to Reduce the Risk of Ischemic Event Associated with Vulnerable Plaque Rupture

Speaker(s)

• 

  Paul A. Gurbel, MD, FSCAI

  Director
  Sinai Center for Thrombosis Research and Drug Development
  Baltimore, Maryland, United States

  Disclosure(s): Werfen: Grant/Research Support (Ongoing)